nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Rivastigmine—Alzheimer's disease	0.211	0.432	CbGbCtD
Conivaptan—CYP3A4—Donepezil—Alzheimer's disease	0.169	0.345	CbGbCtD
Conivaptan—CYP3A4—Galantamine—Alzheimer's disease	0.109	0.223	CbGbCtD
Conivaptan—Atrial arrhythmia—Galantamine—Alzheimer's disease	0.0185	0.0494	CcSEcCtD
Conivaptan—Arrhythmia supraventricular—Galantamine—Alzheimer's disease	0.0132	0.0354	CcSEcCtD
Conivaptan—Atrial arrhythmia—Memantine—Alzheimer's disease	0.013	0.0348	CcSEcCtD
Conivaptan—Arrhythmia supraventricular—Memantine—Alzheimer's disease	0.0093	0.0249	CcSEcCtD
Conivaptan—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00393	0.0105	CcSEcCtD
Conivaptan—Cardiac failure—Galantamine—Alzheimer's disease	0.00381	0.0102	CcSEcCtD
Conivaptan—Dehydration—Galantamine—Alzheimer's disease	0.00346	0.00925	CcSEcCtD
Conivaptan—Sepsis—Donepezil—Alzheimer's disease	0.00345	0.00922	CcSEcCtD
Conivaptan—Candida infection—Memantine—Alzheimer's disease	0.00344	0.00921	CcSEcCtD
Conivaptan—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.0034	0.00909	CcSEcCtD
Conivaptan—Hypokalaemia—Galantamine—Alzheimer's disease	0.00339	0.00906	CcSEcCtD
Conivaptan—Candida infection—Rivastigmine—Alzheimer's disease	0.00337	0.00901	CcSEcCtD
Conivaptan—Urine output increased—Memantine—Alzheimer's disease	0.00326	0.00872	CcSEcCtD
Conivaptan—Urine output increased—Rivastigmine—Alzheimer's disease	0.00319	0.00853	CcSEcCtD
Conivaptan—Sepsis—Memantine—Alzheimer's disease	0.00313	0.00837	CcSEcCtD
Conivaptan—Sepsis—Rivastigmine—Alzheimer's disease	0.00306	0.00819	CcSEcCtD
Conivaptan—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00304	0.00814	CcSEcCtD
Conivaptan—Phlebitis—Memantine—Alzheimer's disease	0.00304	0.00813	CcSEcCtD
Conivaptan—Thirst—Donepezil—Alzheimer's disease	0.00303	0.0081	CcSEcCtD
Conivaptan—Polyuria—Memantine—Alzheimer's disease	0.00298	0.00797	CcSEcCtD
Conivaptan—Phlebitis—Rivastigmine—Alzheimer's disease	0.00297	0.00795	CcSEcCtD
Conivaptan—Pollakiuria—Galantamine—Alzheimer's disease	0.00297	0.00795	CcSEcCtD
Conivaptan—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00295	0.0079	CcSEcCtD
Conivaptan—Cardiac failure—Donepezil—Alzheimer's disease	0.00295	0.0079	CcSEcCtD
Conivaptan—Polyuria—Rivastigmine—Alzheimer's disease	0.00292	0.0078	CcSEcCtD
Conivaptan—Hyperglycaemia—Galantamine—Alzheimer's disease	0.0029	0.00776	CcSEcCtD
Conivaptan—Hyponatraemia—Donepezil—Alzheimer's disease	0.00289	0.00774	CcSEcCtD
Conivaptan—Pneumonia—Galantamine—Alzheimer's disease	0.00288	0.00771	CcSEcCtD
Conivaptan—Urinary tract infection—Galantamine—Alzheimer's disease	0.00279	0.00745	CcSEcCtD
Conivaptan—Atrial fibrillation—Memantine—Alzheimer's disease	0.00276	0.00739	CcSEcCtD
Conivaptan—Haematuria—Galantamine—Alzheimer's disease	0.00273	0.00731	CcSEcCtD
Conivaptan—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.0027	0.00723	CcSEcCtD
Conivaptan—Thirst—Rivastigmine—Alzheimer's disease	0.00269	0.0072	CcSEcCtD
Conivaptan—Cardiac failure—Memantine—Alzheimer's disease	0.00268	0.00718	CcSEcCtD
Conivaptan—Hypoglycaemia—Memantine—Alzheimer's disease	0.00268	0.00718	CcSEcCtD
Conivaptan—Dehydration—Donepezil—Alzheimer's disease	0.00268	0.00717	CcSEcCtD
Conivaptan—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00263	0.00704	CcSEcCtD
Conivaptan—Hyponatraemia—Memantine—Alzheimer's disease	0.00263	0.00703	CcSEcCtD
Conivaptan—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00262	0.00702	CcSEcCtD
Conivaptan—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00262	0.00702	CcSEcCtD
Conivaptan—Hypokalaemia—Donepezil—Alzheimer's disease	0.00262	0.00702	CcSEcCtD
Conivaptan—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00257	0.00688	CcSEcCtD
Conivaptan—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00254	0.0068	CcSEcCtD
Conivaptan—Oedema peripheral—Galantamine—Alzheimer's disease	0.00253	0.00678	CcSEcCtD
Conivaptan—Urethral disorder—Galantamine—Alzheimer's disease	0.00252	0.00675	CcSEcCtD
Conivaptan—Dehydration—Memantine—Alzheimer's disease	0.00243	0.00651	CcSEcCtD
Conivaptan—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00239	0.0064	CcSEcCtD
Conivaptan—Cardiac disorder—Galantamine—Alzheimer's disease	0.00239	0.00639	CcSEcCtD
Conivaptan—Hypokalaemia—Memantine—Alzheimer's disease	0.00238	0.00637	CcSEcCtD
Conivaptan—Dehydration—Rivastigmine—Alzheimer's disease	0.00238	0.00637	CcSEcCtD
Conivaptan—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00234	0.00626	CcSEcCtD
Conivaptan—Angiopathy—Galantamine—Alzheimer's disease	0.00233	0.00625	CcSEcCtD
Conivaptan—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00233	0.00623	CcSEcCtD
Conivaptan—Pollakiuria—Donepezil—Alzheimer's disease	0.0023	0.00616	CcSEcCtD
Conivaptan—Mental disorder—Galantamine—Alzheimer's disease	0.00225	0.00603	CcSEcCtD
Conivaptan—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00225	0.00601	CcSEcCtD
Conivaptan—Malnutrition—Galantamine—Alzheimer's disease	0.00224	0.00599	CcSEcCtD
Conivaptan—Pneumonia—Donepezil—Alzheimer's disease	0.00223	0.00598	CcSEcCtD
Conivaptan—Infestation—Donepezil—Alzheimer's disease	0.00222	0.00594	CcSEcCtD
Conivaptan—Infestation NOS—Donepezil—Alzheimer's disease	0.00222	0.00594	CcSEcCtD
Conivaptan—Urinary tract infection—Donepezil—Alzheimer's disease	0.00216	0.00578	CcSEcCtD
Conivaptan—Haematuria—Donepezil—Alzheimer's disease	0.00212	0.00567	CcSEcCtD
Conivaptan—Pollakiuria—Memantine—Alzheimer's disease	0.00209	0.00559	CcSEcCtD
Conivaptan—Anaemia—Galantamine—Alzheimer's disease	0.00207	0.00554	CcSEcCtD
Conivaptan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00204	0.00547	CcSEcCtD
Conivaptan—Hyperglycaemia—Memantine—Alzheimer's disease	0.00204	0.00546	CcSEcCtD
Conivaptan—Pneumonia—Memantine—Alzheimer's disease	0.00203	0.00543	CcSEcCtD
Conivaptan—Infestation NOS—Memantine—Alzheimer's disease	0.00202	0.0054	CcSEcCtD
Conivaptan—Infestation—Memantine—Alzheimer's disease	0.00202	0.0054	CcSEcCtD
Conivaptan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.002	0.00534	CcSEcCtD
Conivaptan—Pneumonia—Rivastigmine—Alzheimer's disease	0.00198	0.00531	CcSEcCtD
Conivaptan—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00197	0.00528	CcSEcCtD
Conivaptan—Infestation—Rivastigmine—Alzheimer's disease	0.00197	0.00528	CcSEcCtD
Conivaptan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00197	0.00527	CcSEcCtD
Conivaptan—Oedema peripheral—Donepezil—Alzheimer's disease	0.00196	0.00526	CcSEcCtD
Conivaptan—Urinary tract infection—Memantine—Alzheimer's disease	0.00196	0.00525	CcSEcCtD
Conivaptan—Urethral disorder—Donepezil—Alzheimer's disease	0.00195	0.00523	CcSEcCtD
Conivaptan—Hypertension—Galantamine—Alzheimer's disease	0.00193	0.00517	CcSEcCtD
Conivaptan—Haematuria—Memantine—Alzheimer's disease	0.00192	0.00515	CcSEcCtD
Conivaptan—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00192	0.00513	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00189	0.00507	CcSEcCtD
Conivaptan—Haematuria—Rivastigmine—Alzheimer's disease	0.00188	0.00503	CcSEcCtD
Conivaptan—Dry mouth—Galantamine—Alzheimer's disease	0.00187	0.00499	CcSEcCtD
Conivaptan—Confusional state—Galantamine—Alzheimer's disease	0.00184	0.00493	CcSEcCtD
Conivaptan—Nervous system disorder—Galantamine—Alzheimer's disease	0.00179	0.0048	CcSEcCtD
Conivaptan—Urinary tract disorder—Memantine—Alzheimer's disease	0.00179	0.00478	CcSEcCtD
Conivaptan—Oedema peripheral—Memantine—Alzheimer's disease	0.00178	0.00477	CcSEcCtD
Conivaptan—Skin disorder—Galantamine—Alzheimer's disease	0.00178	0.00475	CcSEcCtD
Conivaptan—Urethral disorder—Memantine—Alzheimer's disease	0.00177	0.00475	CcSEcCtD
Conivaptan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00175	0.00468	CcSEcCtD
Conivaptan—Mental disorder—Donepezil—Alzheimer's disease	0.00175	0.00467	CcSEcCtD
Conivaptan—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00175	0.00467	CcSEcCtD
Conivaptan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00174	0.00465	CcSEcCtD
Conivaptan—Malnutrition—Donepezil—Alzheimer's disease	0.00174	0.00464	CcSEcCtD
Conivaptan—Erythema—Donepezil—Alzheimer's disease	0.00174	0.00464	CcSEcCtD
Conivaptan—Hypotension—Galantamine—Alzheimer's disease	0.00171	0.00457	CcSEcCtD
Conivaptan—Cardiac disorder—Memantine—Alzheimer's disease	0.00168	0.0045	CcSEcCtD
Conivaptan—Insomnia—Galantamine—Alzheimer's disease	0.00165	0.00442	CcSEcCtD
Conivaptan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00164	0.0044	CcSEcCtD
Conivaptan—Angiopathy—Memantine—Alzheimer's disease	0.00164	0.0044	CcSEcCtD
Conivaptan—Mediastinal disorder—Memantine—Alzheimer's disease	0.00163	0.00437	CcSEcCtD
Conivaptan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00161	0.0043	CcSEcCtD
Conivaptan—Anaemia—Donepezil—Alzheimer's disease	0.0016	0.00429	CcSEcCtD
Conivaptan—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.0016	0.00427	CcSEcCtD
Conivaptan—Mental disorder—Memantine—Alzheimer's disease	0.00159	0.00424	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00158	0.00422	CcSEcCtD
Conivaptan—Malnutrition—Memantine—Alzheimer's disease	0.00158	0.00422	CcSEcCtD
Conivaptan—Constipation—Galantamine—Alzheimer's disease	0.00156	0.00418	CcSEcCtD
Conivaptan—Mental disorder—Rivastigmine—Alzheimer's disease	0.00155	0.00415	CcSEcCtD
Conivaptan—Malnutrition—Rivastigmine—Alzheimer's disease	0.00154	0.00413	CcSEcCtD
Conivaptan—Erythema—Rivastigmine—Alzheimer's disease	0.00154	0.00413	CcSEcCtD
Conivaptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.00151	0.00403	CcSEcCtD
Conivaptan—Hypertension—Donepezil—Alzheimer's disease	0.0015	0.00401	CcSEcCtD
Conivaptan—Anaemia—Memantine—Alzheimer's disease	0.00146	0.0039	CcSEcCtD
Conivaptan—Dry mouth—Donepezil—Alzheimer's disease	0.00145	0.00387	CcSEcCtD
Conivaptan—Body temperature increased—Galantamine—Alzheimer's disease	0.00145	0.00387	CcSEcCtD
Conivaptan—Confusional state—Donepezil—Alzheimer's disease	0.00143	0.00382	CcSEcCtD
Conivaptan—Anaemia—Rivastigmine—Alzheimer's disease	0.00143	0.00381	CcSEcCtD
Conivaptan—Infection—Donepezil—Alzheimer's disease	0.00141	0.00377	CcSEcCtD
Conivaptan—Nervous system disorder—Donepezil—Alzheimer's disease	0.00139	0.00372	CcSEcCtD
Conivaptan—Hypertension—Memantine—Alzheimer's disease	0.00136	0.00364	CcSEcCtD
Conivaptan—Hypertension—Rivastigmine—Alzheimer's disease	0.00133	0.00356	CcSEcCtD
Conivaptan—Hypotension—Donepezil—Alzheimer's disease	0.00132	0.00354	CcSEcCtD
Conivaptan—Dry mouth—Memantine—Alzheimer's disease	0.00131	0.00351	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.0013	0.00349	CcSEcCtD
Conivaptan—Confusional state—Memantine—Alzheimer's disease	0.0013	0.00347	CcSEcCtD
Conivaptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.00128	0.00343	CcSEcCtD
Conivaptan—Insomnia—Donepezil—Alzheimer's disease	0.00128	0.00343	CcSEcCtD
Conivaptan—Infection—Memantine—Alzheimer's disease	0.00128	0.00342	CcSEcCtD
Conivaptan—Confusional state—Rivastigmine—Alzheimer's disease	0.00127	0.00339	CcSEcCtD
Conivaptan—Nervous system disorder—Memantine—Alzheimer's disease	0.00126	0.00338	CcSEcCtD
Conivaptan—Diarrhoea—Galantamine—Alzheimer's disease	0.00125	0.00335	CcSEcCtD
Conivaptan—Infection—Rivastigmine—Alzheimer's disease	0.00125	0.00334	CcSEcCtD
Conivaptan—Skin disorder—Memantine—Alzheimer's disease	0.00125	0.00334	CcSEcCtD
Conivaptan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00123	0.0033	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00122	0.00327	CcSEcCtD
Conivaptan—Skin disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00327	CcSEcCtD
Conivaptan—Pain—Donepezil—Alzheimer's disease	0.00121	0.00324	CcSEcCtD
Conivaptan—Constipation—Donepezil—Alzheimer's disease	0.00121	0.00324	CcSEcCtD
Conivaptan—Hypotension—Memantine—Alzheimer's disease	0.0012	0.00322	CcSEcCtD
Conivaptan—Hypotension—Rivastigmine—Alzheimer's disease	0.00118	0.00315	CcSEcCtD
Conivaptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.00117	0.00312	CcSEcCtD
Conivaptan—Insomnia—Memantine—Alzheimer's disease	0.00116	0.00311	CcSEcCtD
Conivaptan—Vomiting—Galantamine—Alzheimer's disease	0.00116	0.00311	CcSEcCtD
Conivaptan—Headache—Galantamine—Alzheimer's disease	0.00115	0.00306	CcSEcCtD
Conivaptan—Insomnia—Rivastigmine—Alzheimer's disease	0.00114	0.00305	CcSEcCtD
Conivaptan—Body temperature increased—Donepezil—Alzheimer's disease	0.00112	0.003	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00111	0.00297	CcSEcCtD
Conivaptan—Pain—Memantine—Alzheimer's disease	0.0011	0.00294	CcSEcCtD
Conivaptan—Constipation—Memantine—Alzheimer's disease	0.0011	0.00294	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00109	0.00291	CcSEcCtD
Conivaptan—Nausea—Galantamine—Alzheimer's disease	0.00109	0.00291	CcSEcCtD
Conivaptan—Pain—Rivastigmine—Alzheimer's disease	0.00108	0.00288	CcSEcCtD
Conivaptan—Constipation—Rivastigmine—Alzheimer's disease	0.00108	0.00288	CcSEcCtD
Conivaptan—Feeling abnormal—Memantine—Alzheimer's disease	0.00106	0.00284	CcSEcCtD
Conivaptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00104	0.00277	CcSEcCtD
Conivaptan—Body temperature increased—Memantine—Alzheimer's disease	0.00102	0.00272	CcSEcCtD
Conivaptan—Pruritus—Donepezil—Alzheimer's disease	0.001	0.00268	CcSEcCtD
Conivaptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000995	0.00266	CcSEcCtD
Conivaptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000969	0.00259	CcSEcCtD
Conivaptan—Pruritus—Memantine—Alzheimer's disease	0.00091	0.00243	CcSEcCtD
Conivaptan—Vomiting—Donepezil—Alzheimer's disease	0.000901	0.00241	CcSEcCtD
Conivaptan—Pruritus—Rivastigmine—Alzheimer's disease	0.00089	0.00238	CcSEcCtD
Conivaptan—Headache—Donepezil—Alzheimer's disease	0.000888	0.00237	CcSEcCtD
Conivaptan—Diarrhoea—Memantine—Alzheimer's disease	0.00088	0.00235	CcSEcCtD
Conivaptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000861	0.0023	CcSEcCtD
Conivaptan—Nausea—Donepezil—Alzheimer's disease	0.000842	0.00225	CcSEcCtD
Conivaptan—Vomiting—Memantine—Alzheimer's disease	0.000818	0.00219	CcSEcCtD
Conivaptan—Headache—Memantine—Alzheimer's disease	0.000806	0.00216	CcSEcCtD
Conivaptan—Vomiting—Rivastigmine—Alzheimer's disease	0.0008	0.00214	CcSEcCtD
Conivaptan—Headache—Rivastigmine—Alzheimer's disease	0.000788	0.00211	CcSEcCtD
Conivaptan—Nausea—Memantine—Alzheimer's disease	0.000764	0.00204	CcSEcCtD
Conivaptan—Nausea—Rivastigmine—Alzheimer's disease	0.000748	0.002	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000471	0.00342	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000469	0.0034	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000468	0.00339	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CDK5—Alzheimer's disease	0.000457	0.00332	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CDK5—Alzheimer's disease	0.000454	0.00329	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR6—Alzheimer's disease	0.00044	0.00319	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR6—Alzheimer's disease	0.000437	0.00317	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000436	0.00316	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000413	0.003	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.00041	0.00298	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00041	0.00298	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000404	0.00293	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GAL—Alzheimer's disease	0.000403	0.00292	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000402	0.00291	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GAL—Alzheimer's disease	0.0004	0.0029	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000393	0.00285	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GAL—Alzheimer's disease	0.000366	0.00265	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GAL—Alzheimer's disease	0.000363	0.00263	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TTR—Alzheimer's disease	0.000357	0.00259	CbGpPWpGaD
Conivaptan—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000356	0.00258	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000355	0.00257	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TTR—Alzheimer's disease	0.000354	0.00257	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000352	0.00255	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000316	0.00229	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000316	0.00229	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCR5—Alzheimer's disease	0.000315	0.00228	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000314	0.00228	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000314	0.00228	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—NPY—Alzheimer's disease	0.000314	0.00228	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000314	0.00228	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCR5—Alzheimer's disease	0.000312	0.00227	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000312	0.00226	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PYY—Alzheimer's disease	0.000312	0.00226	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PYY—Alzheimer's disease	0.000309	0.00224	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000308	0.00223	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000306	0.00222	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000305	0.00221	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CRH—Alzheimer's disease	0.000303	0.0022	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000289	0.0021	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000288	0.00209	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPY—Alzheimer's disease	0.000287	0.00208	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—NPS—Alzheimer's disease	0.000287	0.00208	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000287	0.00208	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000285	0.00207	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPY—Alzheimer's disease	0.000285	0.00207	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000284	0.00206	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IAPP—Alzheimer's disease	0.000283	0.00206	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.00028	0.00203	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CRH—Alzheimer's disease	0.000277	0.00201	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000276	0.002	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—SST—Alzheimer's disease	0.000276	0.002	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000276	0.002	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CRH—Alzheimer's disease	0.000275	0.002	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000274	0.00199	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—SST—Alzheimer's disease	0.000274	0.00199	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDK5—Alzheimer's disease	0.00027	0.00196	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—F2—Alzheimer's disease	0.00027	0.00196	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—APP—Alzheimer's disease	0.000269	0.00195	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDK5—Alzheimer's disease	0.000268	0.00195	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—F2—Alzheimer's disease	0.000268	0.00194	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—APP—Alzheimer's disease	0.000267	0.00194	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPS—Alzheimer's disease	0.000263	0.00191	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000261	0.0019	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPS—Alzheimer's disease	0.000261	0.00189	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR6—Alzheimer's disease	0.00026	0.00189	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.00026	0.00188	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR6—Alzheimer's disease	0.000258	0.00187	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000254	0.00184	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000252	0.00183	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000251	0.00182	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—SST—Alzheimer's disease	0.000251	0.00182	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—SST—Alzheimer's disease	0.000249	0.0018	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000249	0.0018	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—APP—Alzheimer's disease	0.000244	0.00177	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—APP—Alzheimer's disease	0.000242	0.00176	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL2—Alzheimer's disease	0.000241	0.00175	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000239	0.00173	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000238	0.00173	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000236	0.00171	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000234	0.0017	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000233	0.00169	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APH1A—Alzheimer's disease	0.000233	0.00169	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APH1A—Alzheimer's disease	0.000231	0.00168	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00023	0.00167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000229	0.00166	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000227	0.00164	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000225	0.00163	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000225	0.00163	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LRP1—Alzheimer's disease	0.000221	0.0016	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LRP1—Alzheimer's disease	0.00022	0.00159	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GAL—Alzheimer's disease	0.000216	0.00157	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GFAP—Alzheimer's disease	0.000216	0.00157	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GFAP—Alzheimer's disease	0.000214	0.00156	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GAL—Alzheimer's disease	0.000214	0.00156	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—A2M—Alzheimer's disease	0.00019	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.00019	0.00137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—A2M—Alzheimer's disease	0.000189	0.00137	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000188	0.00136	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000186	0.00135	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000184	0.00134	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000183	0.00133	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000178	0.00129	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000177	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000174	0.00126	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000173	0.00125	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.00017	0.00124	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPY—Alzheimer's disease	0.00017	0.00123	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000169	0.00123	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000169	0.00122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPY—Alzheimer's disease	0.000168	0.00122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IAPP—Alzheimer's disease	0.000167	0.00121	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000167	0.00121	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CRH—Alzheimer's disease	0.000164	0.00119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CRH—Alzheimer's disease	0.000163	0.00118	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000161	0.00117	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR5—Alzheimer's disease	0.00016	0.00116	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000158	0.00115	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000157	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPS—Alzheimer's disease	0.000155	0.00113	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000154	0.00112	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPS—Alzheimer's disease	0.000154	0.00112	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000153	0.00111	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—F2—Alzheimer's disease	0.000153	0.00111	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000152	0.0011	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—F2—Alzheimer's disease	0.000151	0.0011	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000151	0.0011	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000148	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SST—Alzheimer's disease	0.000148	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000148	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000147	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GAB2—Alzheimer's disease	0.000147	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NTRK2—Alzheimer's disease	0.000147	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SST—Alzheimer's disease	0.000147	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000147	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CALM1—Alzheimer's disease	0.000146	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000146	0.00106	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APP—Alzheimer's disease	0.000144	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APP—Alzheimer's disease	0.000143	0.00104	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—F2—Alzheimer's disease	0.000139	0.001	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—F2—Alzheimer's disease	0.000138	0.000998	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000136	0.000987	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLCB1—Alzheimer's disease	0.000135	0.00098	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000127	0.000921	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000126	0.000917	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000126	0.000915	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGFR—Alzheimer's disease	0.000126	0.000915	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CREB1—Alzheimer's disease	0.000125	0.000909	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000124	0.0009	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000124	0.000899	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000123	0.000896	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADAM10—Alzheimer's disease	0.000123	0.000893	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—Alzheimer's disease	0.000123	0.000889	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000122	0.000887	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—S100B—Alzheimer's disease	0.000117	0.000851	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—S100B—Alzheimer's disease	0.000116	0.000845	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000112	0.00081	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF2—Alzheimer's disease	0.000111	0.000804	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000108	0.000783	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1R—Alzheimer's disease	0.000107	0.000778	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—Alzheimer's disease	0.000104	0.000751	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—Alzheimer's disease	0.000103	0.000746	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000103	0.000744	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MEF2C—Alzheimer's disease	0.000102	0.000739	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000101	0.00073	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCG—Alzheimer's disease	0.0001	0.000725	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGF—Alzheimer's disease	9.81e-05	0.000711	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGF—Alzheimer's disease	9.74e-05	0.000706	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR5—Alzheimer's disease	9.54e-05	0.000692	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR5—Alzheimer's disease	9.47e-05	0.000687	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—Alzheimer's disease	9.34e-05	0.000677	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—Alzheimer's disease	9.27e-05	0.000672	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALM1—Alzheimer's disease	8.71e-05	0.000632	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—Alzheimer's disease	8.68e-05	0.000629	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—Alzheimer's disease	8.68e-05	0.000629	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALM1—Alzheimer's disease	8.65e-05	0.000627	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—Alzheimer's disease	8.62e-05	0.000625	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—Alzheimer's disease	8.62e-05	0.000625	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CAV1—Alzheimer's disease	8.6e-05	0.000624	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CAV1—Alzheimer's disease	8.54e-05	0.000619	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—Alzheimer's disease	8.29e-05	0.000601	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—Alzheimer's disease	8.23e-05	0.000597	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—F2—Alzheimer's disease	8.19e-05	0.000594	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—F2—Alzheimer's disease	8.13e-05	0.000589	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	8.01e-05	0.000581	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.95e-05	0.000577	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GSK3B—Alzheimer's disease	7.52e-05	0.000545	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GSK3B—Alzheimer's disease	7.46e-05	0.000541	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CREB1—Alzheimer's disease	7.46e-05	0.000541	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INS—Alzheimer's disease	7.41e-05	0.000538	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CREB1—Alzheimer's disease	7.4e-05	0.000537	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INS—Alzheimer's disease	7.36e-05	0.000534	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—Alzheimer's disease	7.3e-05	0.000529	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—Alzheimer's disease	7.24e-05	0.000525	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—Alzheimer's disease	7.17e-05	0.00052	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	7.17e-05	0.00052	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—Alzheimer's disease	7.12e-05	0.000516	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—Alzheimer's disease	6.5e-05	0.000472	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—Alzheimer's disease	6.46e-05	0.000468	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA4—Alzheimer's disease	6.09e-05	0.000442	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	5.73e-05	0.000416	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.57e-05	0.000404	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.53e-05	0.000401	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—Alzheimer's disease	5.52e-05	0.0004	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—Alzheimer's disease	5.48e-05	0.000398	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—Alzheimer's disease	5.48e-05	0.000397	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—Alzheimer's disease	5.45e-05	0.000395	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	5.43e-05	0.000394	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLD3—Alzheimer's disease	5.18e-05	0.000376	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—Alzheimer's disease	5.07e-05	0.000368	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—Alzheimer's disease	5.06e-05	0.000367	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—Alzheimer's disease	5.04e-05	0.000365	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—Alzheimer's disease	5.02e-05	0.000364	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.97e-05	0.00036	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	4.78e-05	0.000347	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.68e-05	0.00034	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—Alzheimer's disease	4.65e-05	0.000337	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ND1—Alzheimer's disease	4.62e-05	0.000335	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—Alzheimer's disease	4.3e-05	0.000312	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—Alzheimer's disease	4.27e-05	0.00031	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—Alzheimer's disease	3.54e-05	0.000257	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—Alzheimer's disease	3.51e-05	0.000255	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—Alzheimer's disease	3.24e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—Alzheimer's disease	3.22e-05	0.000233	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—Alzheimer's disease	2.99e-05	0.000217	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.98e-05	0.000216	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.98e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—Alzheimer's disease	2.97e-05	0.000215	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.85e-05	0.000207	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.75e-05	0.000199	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.65e-05	0.000192	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.31e-05	0.000167	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.28e-05	0.000165	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.16e-05	0.000157	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.16e-05	0.000157	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.12e-05	0.000154	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.01e-05	0.000146	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.9e-05	0.000138	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.84e-05	0.000133	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.58e-05	0.000115	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.58e-05	0.000114	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.44e-05	0.000105	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.3e-05	9.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.21e-05	8.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.21e-05	8.77e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.2e-05	8.69e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.05e-05	7.64e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INS—Alzheimer's disease	1.03e-05	7.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.06e-06	6.57e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.29e-06	6.01e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.17e-06	3.02e-05	CbGpPWpGaD
